These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 27778440)

  • 1. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
    J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
    Hum J; Shatzel JJ; Jou JH; Deloughery TG
    Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.
    Caiano LM; Riva N; Ageno W
    Expert Rev Hematol; 2023 Feb; 16(2):121-129. PubMed ID: 36820873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to manage splanchnic vein thrombosis in patients with liver disease.
    Riva N; Ageno W
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.
    Carlin S; Cuker A; Gatt A; Gendron N; Hernández-Gea V; Meijer K; Siegal DM; Stanworth S; Lisman T; Roberts LN
    J Thromb Haemost; 2024 Sep; 22(9):2653-2669. PubMed ID: 38823454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.
    Hoolwerf EW; Kraaijpoel N; Büller HR; van Es N
    Thromb Res; 2018 Oct; 170():102-108. PubMed ID: 30153564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Weinberg EM; Palecki J; Reddy KR
    Semin Liver Dis; 2019 May; 39(2):195-208. PubMed ID: 30978730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art.
    Monaco G; Bucherini L; Stefanini B; Piscaglia F; Foschi FG; Ielasi L
    World J Gastroenterol; 2023 Sep; 29(33):4962-4974. PubMed ID: 37731994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
    Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
    Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Direct Oral Anticoagulants in Patients with Splanchnic Vein Thrombosis: A Systematic Reviews and Meta-Analysis.
    Wan Y; Guo L; Xiong M
    Clin Appl Thromb Hemost; 2024; 30():10760296241274750. PubMed ID: 39135448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
    Semmler G; Lindorfer A; Schäfer B; Bartl S; Hametner-Schreil S; Gensluckner S; Balcar L; Pomej K; Lampichler K; Trauner M; Aigner E; Datz C; Zoller H; Hofer H; Schöfl R; Mandorfer M; Reiberger T; Scheiner B
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):978-987.e2. PubMed ID: 35533994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
    Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
    Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Li Z; Xu W; Wang L; Chai L; Ageno W; Romeiro FG; Li H; Qi X
    Thromb Haemost; 2023 Nov; 123(11):1072-1088. PubMed ID: 37336474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies.
    Calcaterra I; Tufano A; Strano F; Rufolo P; Donnarumma S; Palermo V; De Ruberto F; Cimino E; Guerrino C; Conca P; Iannuzzo G; Di Minno M
    J Thromb Haemost; 2024 Feb; 22(2):534-544. PubMed ID: 37926192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.